Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 446 entries
Sorted by: Best Match Show Resources per page
Impact Geosciences/h

Geoscience Opportunities for Leadership in Diversity AND Program Evaluation

Burk J.
GSID: Glpn4GrVHFMJ
J Burk - 2019 - books.google.com

This volume focuses on the research achievements of the earth sciences in developing the nation's energy resources and on the efforts that still must be made toward solving current …

Cite
Burk, J. (2019). Impact Geosciences/h. Routledge.
Burk, James. Impact Geosciences/h. Routledge, 2019.
Copy Download .nbib Format: MLA
A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study.

Current therapeutic research, clinical and experimental

Hanžel J, Piletič Ž, Turk M, Eržen B, Šabovič M.
PMID: 26199676
Curr Ther Res Clin Exp. 2015 Jun 06;77:63-5. doi: 10.1016/j.curtheres.2015.06.001. eCollection 2015 Dec.

BACKGROUND: Despite optimum treatment, patients who experience myocardial infarction are still at high risk for future events.OBJECTIVE: We evaluated the effect of 30 days of treatment with combination of low, subtherapeutic doses of fluvastatin and valsartan on arterial stiffness...

Cite
Hanžel J, Piletič Ž, Turk M, et al. A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study. Curr Ther Res Clin Exp. 2015;77:63-5doi: 10.1016/j.curtheres.2015.06.001.
Hanžel, J., Piletič, �. �., Turk, M., Eržen, B., & Šabovič, M. (2015). A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study. Current therapeutic research, clinical and experimental, 7763-5. https://doi.org/10.1016/j.curtheres.2015.06.001
Hanžel, Jurij, et al. "A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study." Current therapeutic research, clinical and experimental vol. 77 (2015): 63-5. doi: https://doi.org/10.1016/j.curtheres.2015.06.001
Hanžel J, Piletič Ž, Turk M, Eržen B, Šabovič M. A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study. Curr Ther Res Clin Exp. 2015 Jun 06;77:63-5. doi: 10.1016/j.curtheres.2015.06.001. eCollection 2015 Dec. PMID: 26199676; PMCID: PMC4506977.
Copy Download .nbib Format: NLM
Multigram Synthesis of 1-.

Tetrahedron letters

Burk M, Wilson N, Herzon SB.
PMID: 26097264
Tetrahedron Lett. 2015 Jun 03;56(23):3231-3234. doi: 10.1016/j.tetlet.2014.12.073.

A synthesis of 1-

Cite
Burk M, Wilson N, Herzon SB. Multigram Synthesis of 1-. Tetrahedron Lett. 2015;56(23):3231-3234doi: 10.1016/j.tetlet.2014.12.073.
Burk, M., Wilson, N., & Herzon, S. B. (2015). Multigram Synthesis of 1-. Tetrahedron letters, 56(23), 3231-3234. https://doi.org/10.1016/j.tetlet.2014.12.073
Burk, Matthew, et al. "Multigram Synthesis of 1-." Tetrahedron letters vol. 56,23 (2015): 3231-3234. doi: https://doi.org/10.1016/j.tetlet.2014.12.073
Burk M, Wilson N, Herzon SB. Multigram Synthesis of 1-. Tetrahedron Lett. 2015 Jun 03;56(23):3231-3234. doi: 10.1016/j.tetlet.2014.12.073. PMID: 26097264; PMCID: PMC4472375.
Copy Download .nbib Format: NLM
A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study.

International journal of psychiatry in clinical practice

Dogruman-Al F, Aslan S, Yalcin S, Kustimur S, Turk S.
PMID: 24946126
Int J Psychiatry Clin Pract. 2009;13(1):82-7. doi: 10.1080/13651500802624738.

Objective. Schizophrenia is a pervasive neuropsychiatric disease of uncertain etiology. We aimed to investigate a possible association between Toxoplasma gondii infection and schizophrenia in this study. Method. We selected individuals with schizophrenia (n=88) and tested them with commercially available...

Cite
Dogruman-Al F, Aslan S, Yalcin S, et al. A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study. Int J Psychiatry Clin Pract. 2009;13(1):82-7doi: 10.1080/13651500802624738.
Dogruman-Al, F., Aslan, S., Yalcin, S., Kustimur, S., & Turk, S. (2009). A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study. International journal of psychiatry in clinical practice, 13(1), 82-7. https://doi.org/10.1080/13651500802624738
Dogruman-Al, Funda, et al. "A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study." International journal of psychiatry in clinical practice vol. 13,1 (2009): 82-7. doi: https://doi.org/10.1080/13651500802624738
Dogruman-Al F, Aslan S, Yalcin S, Kustimur S, Turk S. A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study. Int J Psychiatry Clin Pract. 2009;13(1):82-7. doi: 10.1080/13651500802624738. PMID: 24946126.
Copy Download .nbib Format: NLM
WE-C-217BCD-03: Restricted Data Set Reconstruction Based on Respiration Quality to Improve Prospectively Gated in Vivo Micro-CT of Mice.

Medical physics

Burk L, Lee Y, Lu J, Zhou O.
PMID: 28519969
Med Phys. 2012 Jun;39(6):3949-3950. doi: 10.1118/1.4736119.

PURPOSE: Micro-CT is commonly employed for lung imaging of mice; prospective gating allows for in-vivo imaging of free-breathing subjects. While this technique is successfully executed for healthy animals, results are less consistent for some disease models whose symptoms include...

Cite
Burk L, Lee Y, Lu J, et al. WE-C-217BCD-03: Restricted Data Set Reconstruction Based on Respiration Quality to Improve Prospectively Gated in Vivo Micro-CT of Mice. Med Phys. 2012;39(6):3949-3950doi: 10.1118/1.4736119.
Burk, L., Lee, Y., Lu, J., & Zhou, O. (2012). WE-C-217BCD-03: Restricted Data Set Reconstruction Based on Respiration Quality to Improve Prospectively Gated in Vivo Micro-CT of Mice. Medical physics, 39(6), 3949-3950. https://doi.org/10.1118/1.4736119
Burk, L, et al. "WE-C-217BCD-03: Restricted Data Set Reconstruction Based on Respiration Quality to Improve Prospectively Gated in Vivo Micro-CT of Mice." Medical physics vol. 39,6 (2012): 3949-3950. doi: https://doi.org/10.1118/1.4736119
Burk L, Lee Y, Lu J, Zhou O. WE-C-217BCD-03: Restricted Data Set Reconstruction Based on Respiration Quality to Improve Prospectively Gated in Vivo Micro-CT of Mice. Med Phys. 2012 Jun;39(6):3949-3950. doi: 10.1118/1.4736119. PMID: 28519969.
Copy Download .nbib Format: NLM
Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria.

Case reports in hematology

Patir P, Isik Y, Turk Y, Ugur MC, Ceylan C, Gorgun G, Mete Gokmen N, Saydam G, Sahin F.
PMID: 26347833
Case Rep Hematol. 2015;2015:908087. doi: 10.1155/2015/908087. Epub 2015 Aug 11.

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, progressive, and life-threatening hematopoietic stem cell disorder characterized by complement-mediated intravascular hemolysis and a prothrombotic state. Patients with PNH might have slightly increased risk of infections due to complement-associated defects subsequent to...

Cite
Patir P, Isik Y, Turk Y, et al. Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria. Case Rep Hematol. 2015;2015:908087doi: 10.1155/2015/908087.
Patir, P., Isik, Y., Turk, Y., Ugur, M. C., Ceylan, C., Gorgun, G., Mete Gokmen, N., Saydam, G., & Sahin, F. (2015). Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria. Case reports in hematology, 2015908087. https://doi.org/10.1155/2015/908087
Patir, Pusem, et al. "Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria." Case reports in hematology vol. 2015 (2015): 908087. doi: https://doi.org/10.1155/2015/908087
Patir P, Isik Y, Turk Y, Ugur MC, Ceylan C, Gorgun G, Mete Gokmen N, Saydam G, Sahin F. Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria. Case Rep Hematol. 2015;2015:908087. doi: 10.1155/2015/908087. Epub 2015 Aug 11. PMID: 26347833; PMCID: PMC4548098.
Copy Download .nbib Format: NLM
Predictive factors for biochemical recurrence in radical prostatectomy patients.

Central European journal of urology

Turk H, Celik O, Un S, Yoldas M, İsoglu CS, Karabicak M, Ergani B, Koc G, Zorlu F, Ilbey YO.
PMID: 26855791
Cent European J Urol. 2015;68(4):404-9. doi: 10.5173/ceju.2015.606. Epub 2015 Nov 30.

INTRODUCTION: Radical prostatectomy (RP) is considered the best treatment for the management of localized prostate cancer in patients with life expectancy over 10 years. However, a complete recovery is not guaranteed for all patients who received/underwent RP treatment. Biochemical...

Cite
Turk H, Celik O, Un S, et al. Predictive factors for biochemical recurrence in radical prostatectomy patients. Cent European J Urol. 2015;68(4):404-9doi: 10.5173/ceju.2015.606.
Turk, H., Celik, O., Un, S., Yoldas, M., İsoglu, C. S., Karabicak, M., Ergani, B., Koc, G., Zorlu, F., & Ilbey, Y. O. (2015). Predictive factors for biochemical recurrence in radical prostatectomy patients. Central European journal of urology, 68(4), 404-9. https://doi.org/10.5173/ceju.2015.606
Turk, Hakan, et al. "Predictive factors for biochemical recurrence in radical prostatectomy patients." Central European journal of urology vol. 68,4 (2015): 404-9. doi: https://doi.org/10.5173/ceju.2015.606
Turk H, Celik O, Un S, Yoldas M, İsoglu CS, Karabicak M, Ergani B, Koc G, Zorlu F, Ilbey YO. Predictive factors for biochemical recurrence in radical prostatectomy patients. Cent European J Urol. 2015;68(4):404-9. doi: 10.5173/ceju.2015.606. Epub 2015 Nov 30. PMID: 26855791; PMCID: PMC4742437.
Copy Download .nbib Format: NLM
Model Estimation and Selection towards Unconstrained Real-Time Tracking and Mapping.

IEEE transactions on visualization and computer graphics

Gauglitz S, Sweeney C, Ventura J, Turk M, Höllerer T.
PMID: 26357301
IEEE Trans Vis Comput Graph. 2014 Jun;20(6):825-38. doi: 10.1109/TVCG.2013.243.

We present an approach and prototype implementation to initialization-free real-time tracking and mapping that supports any type of camera motion in 3D environments, that is, parallax-inducing as well as rotation-only motions. Our approach effectively behaves like a keyframe-based Simultaneous...

Cite
Gauglitz S, Sweeney C, Ventura J, et al. Model Estimation and Selection towards Unconstrained Real-Time Tracking and Mapping. IEEE Trans Vis Comput Graph. 2014;20(6):825-38doi: 10.1109/TVCG.2013.243.
Gauglitz, S., Sweeney, C., Ventura, J., Turk, M., & Höllerer, T. (2014). Model Estimation and Selection towards Unconstrained Real-Time Tracking and Mapping. IEEE transactions on visualization and computer graphics, 20(6), 825-38. https://doi.org/10.1109/TVCG.2013.243
Gauglitz, Steffen, et al. "Model Estimation and Selection towards Unconstrained Real-Time Tracking and Mapping." IEEE transactions on visualization and computer graphics vol. 20,6 (2014): 825-38. doi: https://doi.org/10.1109/TVCG.2013.243
Gauglitz S, Sweeney C, Ventura J, Turk M, Höllerer T. Model Estimation and Selection towards Unconstrained Real-Time Tracking and Mapping. IEEE Trans Vis Comput Graph. 2014 Jun;20(6):825-38. doi: 10.1109/TVCG.2013.243. PMID: 26357301.
Copy Download .nbib Format: NLM
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

Thoracic cancer

Turan N, Benekli M, Dane F, Unal OU, Kara HV, Koca D, Balvan O, Eren T, Tastekin D, Helvaci K, Berk V, Demirci U, Ozturk SC, Dogan E, Cetin B, Kucukoner M, Tonyali O, Tufan G, Oztop I, Gumus M, Coskun U, Uner A, Ozet A, Buyukberber S.
PMID: 26763794
Thorac Cancer. 2014 Sep;5(5):398-404. doi: 10.1111/1759-7714.12107. Epub 2014 Aug 25.

INTRODUCTION: We investigated the impact of modern chemotherapy regimens and bevacizumab following pulmonary metastasectomy (PM) from metastatic colorectal cancer (CRC).METHODS: A total of 122 consecutive patients who were curatively resected for pulmonary metastases of CRC in twelve oncology centers...

Cite
Turan N, Benekli M, Dane F, et al. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer. Thorac Cancer. 2014;5(5):398-404doi: 10.1111/1759-7714.12107.
Turan, N., Benekli, M., Dane, F., Unal, O. U., Kara, H. V., Koca, D., Balvan, O., Eren, T., Tastekin, D., Helvaci, K., Berk, V., Demirci, U., Ozturk, S. C., Dogan, E., Cetin, B., Kucukoner, M., Tonyali, O., Tufan, G., Oztop, I., Gumus, M., Coskun, U., Uner, A., Ozet, A., Buyukberber, S. (2014). Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer. Thoracic cancer, 5(5), 398-404. https://doi.org/10.1111/1759-7714.12107
Turan, Nedim, et al. "Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer." Thoracic cancer vol. 5,5 (2014): 398-404. doi: https://doi.org/10.1111/1759-7714.12107
Turan N, Benekli M, Dane F, Unal OU, Kara HV, Koca D, Balvan O, Eren T, Tastekin D, Helvaci K, Berk V, Demirci U, Ozturk SC, Dogan E, Cetin B, Kucukoner M, Tonyali O, Tufan G, Oztop I, Gumus M, Coskun U, Uner A, Ozet A, Buyukberber S. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer. Thorac Cancer. 2014 Sep;5(5):398-404. doi: 10.1111/1759-7714.12107. Epub 2014 Aug 25. PMID: 26763794; PMCID: PMC4704370.
Copy Download .nbib Format: NLM
Progressive liver failure post acute hepatitis A, over a three-month period, resulting in hepatorenal syndrome and death.

Gastroenterology report

Turk T, Al Saadi T, Sawaf B, Alkhatib M, Zakaria MI, Daaboul B.
PMID: 27247182
Gastroenterol Rep (Oxf). 2017 May;5(2):161-164. doi: 10.1093/gastro/gow009. Epub 2016 May 30.

Hepatitis A is a common viral illness worldwide. It usually results in an acute, self-limiting disease and only rarely leads to fulminant hepatic failure or any other complications. During the period of conflict in Syria, and due to the...

Cite
Turk T, Al Saadi T, Sawaf B, et al. Progressive liver failure post acute hepatitis A, over a three-month period, resulting in hepatorenal syndrome and death. Gastroenterol Rep (Oxf). 2016;5(2):161-164doi: 10.1093/gastro/gow009.
Turk, T., Al Saadi, T., Sawaf, B., Alkhatib, M., Zakaria, M. I., & Daaboul, B. (2017). Progressive liver failure post acute hepatitis A, over a three-month period, resulting in hepatorenal syndrome and death. Gastroenterology report, 5(2), 161-164. https://doi.org/10.1093/gastro/gow009
Turk, Tarek, et al. "Progressive liver failure post acute hepatitis A, over a three-month period, resulting in hepatorenal syndrome and death." Gastroenterology report vol. 5,2 (2017): 161-164. doi: https://doi.org/10.1093/gastro/gow009
Turk T, Al Saadi T, Sawaf B, Alkhatib M, Zakaria MI, Daaboul B. Progressive liver failure post acute hepatitis A, over a three-month period, resulting in hepatorenal syndrome and death. Gastroenterol Rep (Oxf). 2017 May;5(2):161-164. doi: 10.1093/gastro/gow009. Epub 2016 May 30. PMID: 27247182; PMCID: PMC5421466.
Copy Download .nbib Format: NLM
On respiratory impairment in cancer cells.

Science (New York, N.Y.)

BURK D, SCHADE AL.
PMID: 13351640
Science. 1956 Aug 10;124(3215):270-2.

No abstract available.

Cite
BURK D, SCHADE AL. On respiratory impairment in cancer cells. Science. 1956;124(3215):270-2
BURK, D., & SCHADE, A. L. (1956). On respiratory impairment in cancer cells. Science (New York, N.Y.), 124(3215), 270-2.
BURK, D, and SCHADE, A L. "On respiratory impairment in cancer cells." Science (New York, N.Y.) vol. 124,3215 (1956): 270-2.
BURK D, SCHADE AL. On respiratory impairment in cancer cells. Science. 1956 Aug 10;124(3215):270-2. PMID: 13351640.
Copy Download .nbib Format: NLM
A measurement of severity of illness.

Journal of clinical psychology

HOLSOPPLE JQ, LORR M, TURK E.
PMID: 13367232
J Clin Psychol. 1956 Oct;12(4):384-6. doi: 10.1002/1097-4679(195610)12:4<384::aid-jclp2270120420>3.0.co;2-v.

No abstract available.

Cite
HOLSOPPLE JQ, LORR M, TURK E. A measurement of severity of illness. J Clin Psychol. 1956;12(4):384-6doi: 10.1002/1097-4679(195610)12:4<384::aid-jclp2270120420>3.0.co;2-v.
HOLSOPPLE, J. Q., LORR, M., & TURK, E. (1956). A measurement of severity of illness. Journal of clinical psychology, 12(4), 384-6. https://doi.org/10.1002/1097-4679(195610)12:4<384::aid-jclp2270120420>3.0.co;2-v
HOLSOPPLE, J Q, et al. "A measurement of severity of illness." Journal of clinical psychology vol. 12,4 (1956): 384-6. doi: https://doi.org/10.1002/1097-4679(195610)12:4<384::aid-jclp2270120420>3.0.co;2-v
HOLSOPPLE JQ, LORR M, TURK E. A measurement of severity of illness. J Clin Psychol. 1956 Oct;12(4):384-6. doi: 10.1002/1097-4679(195610)12:4<384::aid-jclp2270120420>3.0.co;2-v. PMID: 13367232.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 446 entries